Risks, Benefits, and Patients’ Treatment Decisions at the End of Life

Chapter

Abstract

Medicine’s traditional doctor-oriented paternalism has declined rapidly in most Western countries. The rising level of the general public’s education and the simultaneous assertion of personal rights have prompted patients to demand more involvement than ever before in decisions about their care. Many patients want both information and decision-making authority. Numerous studies document this new attitude: Many patients say they want some control, partial or full, over treatment decisions, and only a few patients say they want to maintain sole doctor control. Patient autonomy has, therefore, become medicine’s dominant decision-making ethic, making patient assessments of treatments critically important in end-of-life care.

Keywords

Informed consent End-of-life care SPINES model Domain of terminal care Death with dignity 

References

  1. 1.
    Blanchard CG, Labrecque MS, Ruckdeschel JC, Blanchard EB. Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med. 1988;27(11):1139–45.CrossRefPubMedGoogle Scholar
  2. 2.
    Mazur DJ, Hickam DH. Patients’ preferences for risk disclosure and role in decision making for invasive medical procedures. J Gen Intern Med. 1997;12(2):114–7.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Kraetschmer N, Sharpe N, Urowitz S, Deber RB. How does trust affect patient preferences for participation in decision-making? Health Expect. 2004;7(4):317–26.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Flynn KE, Smith MA, Vanness D. A typology of preferences for participation in health-care decision-making. Soc Sci Med. 2006;63(5):1158–69.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ainslie N, Beisecker AE. Changes in decisions by elderly persons based on treatment description. Arch Intern Med. 1994;154(19):2225–33.CrossRefPubMedGoogle Scholar
  6. 6.
    Gattellari M, Voigt KJ, Butow PN, Tattersall MHN. When the treatment goal is not cure: Are cancer patients equipped to make informed decisions? J Clin Oncol. 2002;20(2):503–13.CrossRefPubMedGoogle Scholar
  7. 7.
    McNutt RA. Shared medical decision making: problems, process, progress. JAMA. 2004;292(20):2516–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Arora NK, McHorney CA. Patient preferences for medical decision making: Who really wants to participate? Med Care. 2000;38(3):335–41.CrossRefPubMedGoogle Scholar
  9. 9.
    Degner LF, Aquino Russell C. Preferences for treatment control among adults with cancer. Res Nurs Health. 1988;11(6):367–74.CrossRefPubMedGoogle Scholar
  10. 10.
    Deber RB, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision making? Arch Intern Med. 1996;156(13):1414–20.CrossRefPubMedGoogle Scholar
  11. 11.
    Keating NL, Landrum MB, Arora NK, et al. Cancer patients’ roles in treatment decisions: Do characteristics of the decision influence roles? J Clin Oncol. 2010;28(28):4364–70.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Barry MJ, Edgman-Levitan S. Shared decision making—the pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–1.CrossRefPubMedGoogle Scholar
  13. 13.
    Sullivan M. The new subjective medicine: taking the patient’s point of view on health care and health. Soc Sci Med. 2003;56(7):1595–604.CrossRefPubMedGoogle Scholar
  14. 14.
    White RB. Case studies in bioethics, case no. 228: a demand to die. Hast Cen Rep. 1975;5(3):9–10.CrossRefGoogle Scholar
  15. 15.
    Baile WF, Buckman R, Lenzi R, et al. SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist. 2000;5(4):302–11.CrossRefPubMedGoogle Scholar
  16. 16.
    Clayton JM, Butow PN, Tattersall MHN. When and how to initiate discussion about prognosis and EOL issues with terminally ill patients. J Pain Symptom Manage. 2005;30(2):132–44.CrossRefPubMedGoogle Scholar
  17. 17.
    Girgis A, Sanson-Fisher RW. Breaking bad news: consensus guidelines for medical practitioners. J Clin Oncol. 1995;13(9):2449–56.CrossRefPubMedGoogle Scholar
  18. 18.
    Fox E, Arnold R, Brody B. Medical ethics education: past, present and future. Yale curriculum in ethical and humanistic medicine. Acad Med. 1995;70(9):761–9.PubMedGoogle Scholar
  19. 19.
    Morris DA, Johnson KS, Ammarell N, et al. What is your understanding of your illness? A communication tool to explore patients’ perspectives of living with advanced illness. J Gen Intern Med. 2012;27(11):1460–6.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Coulehan JL, Platt FW, Egener B, et al. “Let me see if I have this right …”: Words that help build empathy. Ann Intern Med. 2001;135(3):221–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Wenrich MD, Curtis RJ, Shannon SE, et al. Communicating with dying patients within the spectrum of medical care from terminal diagnosis to death. Arch Intern Med. 2001;161(6):868–74.CrossRefPubMedGoogle Scholar
  22. 22.
    Balaban RB. A physician’s guide to talking about end-of-life care. J Gen Intern Med. 2000;15(3):195–200.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Quill TE, Townsend P. Bad news: delivery, dialogue, and dilemmas. Arch Intern Med. 1991;151(3):463–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Quill TE, Arnold RM, Platt F. “I wish things were different”: expressing wishes in response to loss, futility, and unrealistic hopes. Ann Intern Med. 2001;135(7):551–5.CrossRefPubMedGoogle Scholar
  25. 25.
    Fallowfield L. Giving sad and bad news. The Lancet. 1993;341(8843):476–8 (20 Feb).CrossRefGoogle Scholar
  26. 26.
    The Hippocratic Oath, fourth century, B.C.Google Scholar
  27. 27.
    American Medical Association. Principles of Medical Ethics, 1980.Google Scholar
  28. 28.
    Pearlman RA, Jonsen AR. The use of quality-of-life considerations in medical decision-making. J Am Geriatri Soc. 1985;33(5):344–52.CrossRefGoogle Scholar
  29. 29.
    Steinhauser KE, Christakis NA, Clipp EC, et al. Preparing for the end of life: preferences of patients, families, physicians, and other care providers. J Pain Symptom Manage. 2001;22(3):727–37.CrossRefPubMedGoogle Scholar
  30. 30.
    Steinhauser KE, Clipp EC, McNeilly M, et al. In search of a good death: observations of patients, families, and providers. Ann Intern Med. 2000;132(10):825–32.CrossRefPubMedGoogle Scholar
  31. 31.
    Perkins HS, Geppert CMA, Gonzales A, et al. Cross-cultural similarities and differences in attitudes about advance care planning. J Gen Intern Med. 2002;17(1):48–57.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Singer PA, Martin DK, Kelner M. Quality end-of-life care: patients’ perspectives. JAMA. 1999;281(2):163–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Perkins HS, Cortez JD, Hazuda HP. Patients’ diverse beliefs about what happens at the time of death. J Hosp Med. 2012;7(2):110–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Perkins HS, Cortez JD, Hazuda HP. Diversity of patients’ beliefs about the soul after death and their importance in end-of-life care. South Med J. 2012;105(5):266–72.CrossRefPubMedGoogle Scholar
  35. 35.
    Lynn J. Measuring quality of care at the end of life: a statement of principles. J Am Geriatr Soc. 1997;45(4):526–7.CrossRefPubMedGoogle Scholar
  36. 36.
    Field MJ, Cassel CK, editors. Approaching death: improving care at the end of life. Washington, D.C: National Academy Press; 1997.Google Scholar
  37. 37.
    Emanuel EJ, Emanuel LL. The promise of a good death. Lancet. 1998;351(Suppl 2):21–9.CrossRefGoogle Scholar
  38. 38.
    Steinhauser KE, Christakis NA, Clipp EC, et al. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000;284(19):2476–82.CrossRefPubMedGoogle Scholar
  39. 39.
    Perkins HS, Cortez JD, Hazuda HP. Cultural beliefs about a patient’s right time to die: an exploratory study. J Gen Intern Med. 2009;24(11):1240–7.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Slevin ML, Stubbs L, Plant HJ, et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ. 1990;300(6737):1458–60 (02 June).CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Matsuyama R, Reddy S, Smith TJ. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol. 2006;24(21):3490–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Mitera G, Zhang L, Sahgal A, et al. A survey of expectations and understanding of palliative radiotherapy from patients with advanced cancer. Clin Oncol. 2012;24(2):134–8.CrossRefGoogle Scholar
  43. 43.
    Weeks JC, Catalano PJ, Cronin A, et al. Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med. 2012;367(17):1616–25.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Taffet GE, Teasdale TA, Luchi RJ. In-hospital cardiopulmonary resuscitation. JAMA. 1988;260(14):2069–72.CrossRefPubMedGoogle Scholar
  45. 45.
    Vitelli CE, Cooper K, Rogatko A, Brennan MF. Cardiopulmonary resuscitation and the patient with cancer. J Clin Oncol. 1991;9(1):111–5.CrossRefPubMedGoogle Scholar
  46. 46.
    Arber S, Vandrevala T, Daly T, Hampson S. Understanding gender differences in older people’s attitudes towards life-prolonging medical technologies. J Aging Stud. 2008;22(4):366–75.CrossRefGoogle Scholar
  47. 47.
    Froberg DG, Kane RL. Methodology for measuring health-state preferences—II. Scaling methods. J Clin Epidemiol. 1989;42(5):459–71.CrossRefPubMedGoogle Scholar
  48. 48.
    Pearlman RA, Cain KC, Patrick DL, et al. Insights pertaining to patient assessments of states worse than death. J Clin Ethics. 1993;4(1):33–41.PubMedGoogle Scholar
  49. 49.
    Patrick DL, Starks HE, Cain KC, Uhlmann RF, Pearlman RA. Measuring preferences for health states worse than death. Med Decis Mak. 1994;14(1):9–18.CrossRefGoogle Scholar
  50. 50.
    Hendin H. Selling death and dignity. Hast Cen Rep. 1995;25(3):19–22.CrossRefGoogle Scholar
  51. 51.
    Chochinov HM, Hack T, Hassard T, et al. Dignity in the terminally ill: a cross-sectional cohort study. Lancet. 2002;360(9350):2026–30 (21/28 Dec).CrossRefPubMedGoogle Scholar
  52. 52.
    Vanderpool HY. The ethics of terminal care. JAMA. 1978;239(9):850–2.CrossRefPubMedGoogle Scholar
  53. 53.
    Shultz DS, Carnevale FA. Engagement and suffering in responsible caregiving: on overcoming maleficence in health care. Theor Med. 1996;17(3):189–207.CrossRefGoogle Scholar
  54. 54.
    Danis M, Garrett J, Harris R, Patrick DL. Stability of choices about life-sustaining treatments. Ann Intern Med. 1994;120(7):567–73.CrossRefPubMedGoogle Scholar
  55. 55.
    Ganzini L, Lee MA, Heintz RT, Bloom JD, Fenn DS. The effect of depression treatment on elderly patients’ preferences for life-sustaining medical therapy. Am J Psychiatry. 1994;151(11):1631–6.CrossRefPubMedGoogle Scholar
  56. 56.
    Rosenfeld KE, Wenger NS, Phillips RS, et al. Factors associated with change in resuscitation preference of seriously ill patients. Arch Intern Med. 1996;156(14):1558–64.CrossRefPubMedGoogle Scholar
  57. 57.
    Ditto PH, Smucker WD, Danks JH, et al. Stability of older adults’ preferences for life-sustaining medical treatment. Health Psych. 2003;22(6):605–15.CrossRefGoogle Scholar
  58. 58.
    Everhart MA, Pearlman RA. Stability of patient preferences regarding life-sustaining treatments. Chest. 1990;97(1):159–64.CrossRefPubMedGoogle Scholar
  59. 59.
    Lockhart LK, Ditto PH, Danks JH, Coppola KM, Smucker WD. The stability of older adults’ judgments of fates better and worse than death. Death Studies. 2001;25(4):299–317.CrossRefPubMedGoogle Scholar
  60. 60.
    McParland E, Likourezos A, Chichin E, Castor T, Paris BEC. Stability of preferences regarding life-sustaining treatment: a two-year prospective study of nursing home residents. Mt Sinai J Med. 2003;70(2):85–92.PubMedGoogle Scholar
  61. 61.
    Ditto PH, Jacobson JA, Smucker WD, Danks JH, Fagerlin A. Context changes choices: a prospective study of the effects of hospitalization on life-sustaining treatment preferences. Med Decis Making. 2006;26(4):313–22.CrossRefPubMedGoogle Scholar
  62. 62.
    Sehgal A, Galbraith A, Chesney M, et al. How strictly do dialysis patients want their advance directives followed? JAMA. 1992;267(1):59–63.CrossRefPubMedGoogle Scholar
  63. 63.
    McKinley ED, Garrett JM, Evans AT, Danis M. Differences in end-of-life decision making among black and white ambulatory cancer patients. J Gen Intern Med. 1996;11(11):651–6.CrossRefPubMedGoogle Scholar
  64. 64.
    Blackhall LJ, Frank G, Murphy ST, et al. Ethnicity and attitudes toward life sustaining technology. Soc Sci Med. 1999;48(12):1779–89.CrossRefPubMedGoogle Scholar
  65. 65.
    Barnato AE, Anthony DL, Skinner J, Gallagher PM, Fisher ES. Racial and ethnic difference in preferences for end-of-life treatment. J Gen Intern Med. 2009;24(6):695–701.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Cykert S, Joines JD, Kissling G, Hansen CL. Racial differences in patients’ perceptions of debilitated health states. J Gen Intern Med. 1999;14(4):217–22.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Appelbaum PS, Roth LH, Kidz C. The therapeutic misconception: informed consent in psychiatric research. Inter J Law Psych. 1982;5(3–4):319–29.CrossRefGoogle Scholar
  68. 68.
    Weinfurt KP, Castel LD, Li Y, et al. The correlation between patient characteristics and expectations of benefit from Phase 1 clinical trials. Cancer. 2003;98(1):166–75.CrossRefPubMedGoogle Scholar
  69. 69.
    Daugherty CK. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. J Clin Oncol. 1999;17(5):1601–17.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2016

Authors and Affiliations

  1. 1.Ecumenical Center for Religion and HealthThe University of Texas Health Science CenterSan AntonioUSA

Personalised recommendations